Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1273.90
-1.15 (-0.09%) Dr. Reddy's Lab - Quaterly Results
Date: 13-05-2026
The Sales for the quarter ended March 2026 of Rs. 38220.00 million declined by -31.29% from Rs. 55629.00 millions.The Net Loss for the quarter ended March 2026 is Rs. -2194.00 millions as compared to Net Profit of Rs. 12007.00 millions of corresponding quarter ended March 2025A decline of 673.00 millions was observed in the OP in the quarter ended March 2026 from 18574.00 millions on QoQ basis.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 38220.00 | 55629.00 | -31.29 | 205328.00 | 231154.00 | -11.17 | 205328.00 | 231154.00 | -11.17 |
| Other Income | 5672.00 | 4144.00 | 36.87 | 16896.00 | 10034.00 | 68.39 | 16896.00 | 10034.00 | 68.39 |
| PBIDT | 673.00 | 18574.00 | -96.38 | 56070.00 | 83852.00 | -33.13 | 56070.00 | 83852.00 | -33.13 |
| Interest | 543.00 | 311.00 | 74.60 | 1483.00 | 1099.00 | 34.94 | 1483.00 | 1099.00 | 34.94 |
| PBDT | 130.00 | 18263.00 | -99.29 | 54587.00 | 82753.00 | -34.04 | 54587.00 | 82753.00 | -34.04 |
| Depreciation | 3185.00 | 2645.00 | 20.42 | 12074.00 | 10394.00 | 16.16 | 12074.00 | 10394.00 | 16.16 |
| PBT | -3055.00 | 15618.00 | -119.56 | 42513.00 | 72359.00 | -41.25 | 42513.00 | 72359.00 | -41.25 |
| TAX | -861.00 | 3611.00 | -123.84 | 10316.00 | 18865.00 | -45.32 | 10316.00 | 18865.00 | -45.32 |
| Deferred Tax | 286.00 | -32.00 | -993.75 | 1139.00 | 960.00 | 18.65 | 1139.00 | 960.00 | 18.65 |
| PAT | -2194.00 | 12007.00 | -118.27 | 32197.00 | 53494.00 | -39.81 | 32197.00 | 53494.00 | -39.81 |
| Equity | 835.00 | 834.00 | 0.12 | 835.00 | 834.00 | 0.12 | 835.00 | 834.00 | 0.12 |
| PBIDTM(%) | 1.76 | 33.39 | -94.73 | 27.31 | 36.28 | -24.72 | 27.31 | 36.28 | -24.72 |